We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Mueller-Klein, Nadine![]() |
|
dc.contributor.author | Risely, Alice![]() |
|
dc.contributor.author | Schmid, Dominik W.![]() |
|
dc.contributor.author | Manser, Marta B.![]() |
|
dc.contributor.author | Clutton-Brock, Tim H.![]() |
|
dc.contributor.author | Sommer, Simone![]() |
|
dc.date.accessioned | 2022-12-07T04:42:24Z | |
dc.date.available | 2022-12-07T04:42:24Z | |
dc.date.issued | 2022-11 | |
dc.description | DATA AVAILABILITY STATEMENT: Data used for this publication is available at https://github.com/Nadine-MK/TB-characterization-paper. | en_US |
dc.description | SUPPLEMENTARY MATERIAL: SUPPLEMENTARY TABLE 1. Summary of information available on Mycobacterium infections in wild meerkats in the Kalahari, South Africa. | en_US |
dc.description | FIGURE S1. Patterns of TB exposure, prevalence of clinical signs and TB-related death over 27 years of research at the Kalahari Meerkat Project (South Africa) illustrating the inter-annual variation and development of TB prevalence within the study population. The numbers of A) study groups and B) study individuals of the study population being not exposed yet (green), exposed (blue), displaying clinical signs of TB (orange) or dying with confirmed TB (red). Means ± SD of each measure were calculated in 3-month increments. | en_US |
dc.description | FIGURE S2. Life trajectories of meerkats (n = 3420). For each individual, respective first (birth or entering into the study population) and last (death or disappearance) dates, as well as transitions between TB states are shown. Individuals were on average exposed to TB for 1.4 years before the onset of clinical signs and survived on average until 6.6 months after developing clinical TB. Individuals are sorted by birth date. | en_US |
dc.description.abstract | Infections with tuberculosis (TB)-causing agents of the Mycobacterium tuberculosis complex threaten human, livestock and wildlife health globally due to the high capacity to cross trans-species boundaries. Tuberculosis is a cryptic disease characterized by prolonged, sometimes lifelong subclinical infections, complicating disease monitoring. Consequently, our understanding of infection risk, disease progression, and mortality across species affected by TB remains limited. The TB agent Mycobacterium suricattae was first recorded in the late 1990s in a wild population of meerkats inhabiting the Kalahari in South Africa and has since spread considerably, becoming a common cause of meerkat mortality. This offers an opportunity to document the epidemiology of naturally spreading TB in a wild population. Here, we synthesize more than 25 years’ worth of TB reporting and social interaction data across 3420 individuals to track disease spread, and quantify rates of TB social exposure, progression, and mortality. We found that most meerkats had been exposed to the pathogen within eight years of first detection in the study area, with exposure reaching up to 95% of the population. Approximately one quarter of exposed individuals progressed to clinical TB stages, followed by physical deterioration and death within a few months. Since emergence, 11.6% of deaths were attributed to TB, although the true toll of TB-related mortality is likely higher. Lastly, we observed marked variation in disease progression among individuals, suggesting inter-individual differences in both TB susceptibility and resistance. Our results highlight that TB prevalence and mortality could be higher than previously reported, particularly in species or populations with complex social group dynamics. Long-term studies, such as the present one, allow us to assess temporal variation in disease prevalence and progression and quantify exposure, which is rarely measured in wildlife. Long-term studies are highly valuable tools to explore disease emergence and ecology and study host–pathogen co-evolutionary dynamics in general, and its impact on social mammals. | en_US |
dc.description.department | Mammal Research Institute | en_US |
dc.description.librarian | hj2022 | en_US |
dc.description.sponsorship | Human Frontier Science Program; European Research Council; MAVA Foundation; Swiss National Science Foundation; Deutsche Forschungsgemeinschaft. Open Access funding enabled and organized by Projekt DEAL. | en_US |
dc.description.uri | http://wileyonlinelibrary.com/journal/tbed | en_US |
dc.identifier.citation | Müller-Klein, N., Risely, A., Schmid, D. W., Manser, M., Clutton-Brock, T., & Sommer, S. (2022). Two decades of tuberculosis surveillance reveal disease spread, high levels of exposure and mortality and marked variation in disease progression in wild meerkats. Transboundary and Emerging Diseases, 69, 3274–3284. https://doi.org/10.1111/tbed.14679. | en_US |
dc.identifier.doi | 10.1111/tbed.14679 | |
dc.identifier.issn | 1865-1674 (print) | |
dc.identifier.issn | 1865-1682 (online) | |
dc.identifier.uri | https://repository.up.ac.za/handle/2263/88665 | |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | © 2022 The Authors. Transboundary and Emerging Diseases published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License. | en_US |
dc.subject | Individual life-history trajectories | en_US |
dc.subject | Long-term surveillance | en_US |
dc.subject | Meerkat (Suricata suricatta) | en_US |
dc.subject | South Africa (SA) | en_US |
dc.subject | Tuberculosis (TB) | en_US |
dc.subject | Mycobacterium tuberculosis (MTB) | en_US |
dc.subject | Wildlife disease | en_US |
dc.title | Two decades of tuberculosis surveillance reveal disease spread, high levels of exposure and mortality and marked variation in disease progression in wild meerkats | en_US |
dc.type | Article | en_US |